HIV Care Accessibility and Health Outcomes

Equitable access to HIV care is fundamental to improving health outcomes and achieving global targets for diagnosis, treatment and viral suppression. Barriers to care arise at multiple levels: geographic distance to facilities, transportation costs, clinic capacity and social stigma. These structural impediments influence early diagnosis, retention in care and the ability to achieve and maintain viral suppression, which in turn affects individual prognosis and onward transmission risk. Populations in rural or resource‐limited settings often face longer travel times, fewer specialised services and lower rates of early detection, whereas urban centres may offer more comprehensive care but still encounter disparities among marginalised groups. Addressing these challenges requires integrated strategies that combine decentralised service delivery, community‐based testing, task‐shifting and targeted support to overcome socioeconomic and logistical hurdles. Such interventions have demonstrated improvements in treatment uptake, adherence and long-term survival, highlighting the interconnected nature of accessibility and outcome metrics across diverse settings.

Research from Nature Portfolio

Recent studies have quantified travel-time inequities to antiretroviral therapy in southern Africa by integrating nationally representative survey data with spatial prevalence mapping. Analysis in Eswatini, Malawi and Zambia revealed that a substantial proportion of people living with HIV spend more than one hour travelling to the nearest treatment centre, with rural residents and women disproportionately affected. In Malawi and Zambia over half of those on treatment face journeys exceeding one hour, and up to one in five travel more than two hours. These findings underscore the need for geographically tailored interventions, such as community drug distribution points and mobile clinics, to reduce delays in treatment initiation and to promote sustained engagement in care.

HIV Care Accessibility and Health Outcomes publication trend

The graph below shows the total number of articles in hiv care accessibility and health outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Antiretroviral therapy (ART): A combination of medications that suppress HIV replication and allow immune system recovery.

Viral suppression: Reduction of HIV viral load in the blood to undetectable levels, minimising health risks and transmission.

Retention in care: Continuous engagement of a person living with HIV with healthcare services, including regular clinic visits and laboratory monitoring.

Geographic accessibility: Ease of reaching healthcare services, often measured as travel time or distance to the nearest facility.

References

1. Analysis of travel-time to HIV treatment in sub-Saharan Africa reveals inequities in access to antiretrovirals. Communications Medicine (2025).
2. Progress in Early Detection of HIV in Tajikistan. Viruses (2024).
3. Suboptimal geographic accessibility to comprehensive HIV care in the US: regional and urban–rural differences. Journal of the International AIDS Society (2019).
4. The Health Resources and Services Administration’s Ryan White HIV/AIDS Program in rural areas of the United States: Geographic distribution, provider characteristics, and clinical outcomes. PLOS ONE (2020).